On the Record · Gilead Sciences
Gilead Sciences subsidiaries, as it lists them
The subsidiaries Gilead Sciences lists in its latest annual report, with the jurisdiction of each, linked to the filing.
Subsidiaries it lists
| Subsidiary | Jurisdiction |
|---|---|
| Asegua Therapeutics LLC | United States |
| Calla Holdings, LLC | United States |
| Calla Merger Sub, Inc. | United States |
| CymaBay Therapeutics, Inc. | United States |
| Forty Seven, LLC | United States |
| Forty Seven Holdings, LLC | United States |
| Gilead Alberta, LLC | United States |
| Gilead Apollo, LLC | United States |
| Gilead Biopharmaceutics US LLC | United States |
| Gilead Calistoga, LLC | United States |
| Gilead Connecticut, Inc. | United States |
| Gilead Holdings, LLC | United States |
| Gilead Pharmasset LLC | United States |
| Gilead Sciences, LLC | United States |
| Gilead Sciences Holding, LLC | United States |
| Immunomedics, Inc. | United States |
| IBC Pharmaceuticals, Inc. | United States |
| Interius Biotherapeutics, Inc. | United States |
| Kite Pharma, Inc. | United States |
| Kite Pharma, LLC | United States |
| neoKite, Inc. | United States |
| Tmunity Therapeutics, Inc. | United States |
| XinThera, Inc. | United States |
| Gilead Sciences Argentina S.R.L. | Argentina |
| Cytopia Pty. Ltd. | Australia |
| Gilead Sciences Pty. Ltd. | Australia |
| Gilead Sciences YM Australia Pty. Ltd. | Australia |
| YM BioSciences Australia Pty. Ltd. | Australia |
| Gilead Sciences GesmbH | Austria |
| Gilead Sciences Belgium BV | Belgium |
| Gilead Sciences Farmacêutica do Brasil Ltda. | Brazil |
| CymaBay Canada, Ltd. | Canada |
| Gilead Alberta ULC | Canada |
| Gilead Sciences Canada, Inc. | Canada |
| Gilead YM ULC | Canada |
| Gilead Sciences (Shanghai) Consulting Co., Ltd. | China |
| Gilead Sciences Hangzhou Pharmaceutical Co., Ltd. | China |
| Gilead Sciences Shanghai Pharmaceutical Technology Co., Ltd. | China |
| Gilead Sciences Colombia S.A.S. | Colombia |
| Gilead Sciences s.r.o. | Czech Republic |
| Gilead Sciences Denmark ApS | Denmark |
| Gilead Sciences Finland Oy | Finland |
| Gilead Sciences SAS | France |
| Gilead Sciences GmbH | Germany |
| Immunomedics GmbH | Germany |
| MYR GmbH | Germany |
| Gilead Sciences Hellas EPE | Greece |
| Gilead Sciences Hong Kong Limited | Hong Kong |
| Gilead Sciences India Private Limited | India |
| CymaBay Ireland, Limited | Ireland |
| Gilead Apollo Unlimited Company | Ireland |
| Gilead Biopharmaceutics Ireland UC | Ireland |
| Gilead Sciences Ireland Unlimited Company | Ireland |
| Gilead Therapeutics A1 Unlimited Company | Ireland |
| Gilead Sciences Israel Limited | Israel |
| Gilead Sciences S.r.l. | Italy |
| Gilead Sciences KK | Japan |
| Gilead Sciences Luxembourg S.a.r.l. | Luxembourg |
| Gilead Sciences Malaysia Sdn. Bhd. | Malaysia |
| Gilead Sciences Mexico S. de R.L. de C.V. | Mexico |
| Gilead Sciences Netherlands B.V. | Netherlands |
| Kite Pharma EU B.V. | Netherlands |
| KP EU C.V. | Netherlands |
| Gilead Sciences (NZ) | New Zealand |
| Gilead Sciences Norway AS | Norway |
| Gilead Sciences Americas S. de R.L. | Panama |
| Gilead Sciences Poland Sp. z.o.o. | Poland |
| Gilead Sciences, Lda. | Portugal |
| Gilead Sciences (GSR) S.R.L. | Romania |
| Gilead Sciences Russia LLC | Russia |
| Gilead Sciences Arabia Limited Company | Saudi Arabia |
| Gilead Sciences Singapore Pte. Ltd. | Singapore |
| Gilead Sciences Slovakia s.r.o. | Slovakia |
| Gilead Sciences South Africa (Pty) Ltd. | South Africa |
| Gilead Sciences Korea Limited | South Korea |
| Gilead Sciences S.L.U. | Spain |
| Gilead Sciences Sweden AB | Sweden |
| Gilead Sciences Switzerland Sarl | Switzerland |
| Gilead Sciences Ilac Ticaret Limited Sirketi | Turkey |
| CymaBay UK, Ltd. | United Kingdom |
| Gilead Sciences Europe Limited | United Kingdom |
| Gilead Sciences International Limited | United Kingdom |
| Gilead Sciences Limited | United Kingdom |
| MiroBio Ltd. | United Kingdom |
From Exhibit 21 of the 10-K for 2025. Companies must list their significant subsidiaries there and may leave out smaller ones, so this is the company’s own list, not every entity it owns.
Read from Gilead Sciences’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-24. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.